Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor ‐2 high expressing salivary duct carcinomas

ConclusionDual HER2 blockage resulted in CR in patients with HER expressing salivary duct carcinoma and warrants further evaluation in this patient population.

Source: Head and Neck - November 26, 2018 Category: ENT & OMF Authors: Jong Chul Park, T. Martin Ma, Lisa Rooper, Todd Hembrough, Robert D. Foss, Nicole C. Schmitt, Rishi Sawhney, Aaron Flanders, Hyunseok Kang Tags: CASE REPORT Source Type: research